연속 혈당 모니터링 시장 규모, 점유율, 예측, 동향 분석 : 구성요소별(센서[일회용, 이식형], 수신기, 송신기), 연령별(성인, 소아), 최종사용자별(홈케어, 병원/클리닉) - 세계 예측(-2031년)

Continuous Glucose Monitoring Market Size, Share, Forecast, and Trends Analysis by Component (Sensors [Disposable, Implantable], Receivers, Transmitters), Age Group (Adults, Children), End User (Homecare, Hospitals & Clinics)-Global Forecast to 2031

The global continuous glucose monitoring market is projected to reach $31.41 billion by 2031 at a CAGR of 15% from 2024 to 2031.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of the continuous glucose monitoring (CGM) market is driven by lifestyle changes among the population coupled with the growing burden of chronic conditions such as diabetes, the benefits offered by CGM over conventional glucose monitoring, and the use of CGM by athletes and fitness enthusiasts. However, high costs and product recalls of CGM devices restrain the growth of this market.

Furthermore, technological advancements in CGM devices, a shift toward personalized care and, rising health awareness, and increasing accessibility for diabetes care devices in developing countries are expected to generate market growth opportunities. However, the high number of people living undiagnosed with diabetes patients and problems related to the adhesiveness, reliability, and accuracy of CGM devices are major challenges in the global continuous glucose monitoring market.

The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry in the past three to four years. The key players operating in the continuous glucose monitoring market are DexCom, Inc. (US), Abbott Laboratories (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Medtronic plc (Ireland), Nemaura Medical Inc. (UK), LifeScan, Inc. (US), Senseonics Holdings, Inc. (U.S.), A. Menarini Diagnostics S.r.l (Italy), Medtrum. Technologies, Inc. (Shanghai.), and B. Braun SE (Germany).

Among all the components studied in this report, in 2024, the sensors segment is expected to account for the largest share of 52.4% of the continuous glucose monitoring market. The sensors segment is further segmented into disposable sensors and implantable sensors. The large market segment is attributed to the high demand for continuous glucose monitoring and frequent purchases of sensors compared to receivers and transmitters. Sensors require more frequent replacement compared to other components. Disposable sensors are replaced in 7 to 14 days after placement while implantable sensors can be replaced in 150-180 days.

Among all the age groups studied in this report, in 2024, the adult segment is expected to account for a larger share of the continuous glucose monitoring market. This segment's large market share can be attributed to the high proportion of the geriatric population with diabetes and changing lifestyles leading to diseases such as obesity, depression, anxiety, and cardiovascular diseases.

Among all the end users studied in this report, in 2024, the home care settings segment is expected to account for a larger share of 82.3% of the continuous glucose monitoring market. The large market share of this segment is attributed to factors such as the high prevalence of diabetes worldwide, rising awareness among people, a shift toward preventive healthcare, and easy accessibility to CGM in developed countries. CGM technologies provide numerous advantages in home care settings. There is a growing shift toward home healthcare due to the lack of healthcare professionals and increasing consumer awareness regarding the monitoring of diabetic conditions through CGM, which supports the large market share of the segment.

An in-depth analysis of the geographical scenario of the global continuous glucose monitoring market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. Asia-Pacific is projected to register the highest CAGR of 17.4% during the forecast period. The market growth of this region is attributed to the advancing healthcare infrastructure, growing disposable income, and rising investments by major key market players. Furthermore, economic growth, as well as technological developments support the market growth in Asia-Pacific.

Scope of the Report:

Continuous glucose monitoring Market Assessment-by Component

• Sensors
  • Disposable Sensors
  • Implantable Sensors
• Transmitters
• Receivers

Continuous glucose monitoring Market Assessment-by Age Group

• Adults
• Children

Continuous glucose monitoring Market Assessment-by End User

• Home Care Settings
• Hospitals & Clinics

Continuous glucose monitoring Market Assessment-by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • U.K
  • Italy
  • Spain
  • Sweden
  • Norway
  • Denmark
  • Belgium
  • Rest of Europe (RoE)
• Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • South Korea
  • Rest of Asia-Pacific (RoAPAC)
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• 1.1. Market Definition & Scope
• 1.2. Market Ecosystem
• 1.3. Currency and Limitations
• 1.4. Key Stakeholders

2. Research Methodology

• 2.1. Research Approach
• 2.2. Process of Data Collection and Validation
  • 2.2.1. Secondary Research
  • 2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
• 2.3. Market Sizing and Forecast
  • 2.3.1. Market Size Estimation Approach
  • 2.3.2. Growth Forecast Approach
  • 2.3.3. Market Share Analysis
• 2.4. Assumption for the Study

3. Executive Summary

4. Market Insights

• 4.1. Overview
• 4.2. Drivers
  • 4.2.1. Increasing Prevalence of Diabetes
  • 4.2.2. Increasing Number of People Living Sedentary Lifestyle
  • 4.2.3. Benefits of CGM over Conventional Glucose Monitoring
  • 4.2.4. Use of CGM by Athletes and Fitness Enthusiasts
• 4.3. Restraints
  • 4.3.1. High Cost of CGM Devices
  • 4.3.2. Product Recalls
• 4.4. Opportunities
  • 4.4.1. Technological Advancements in CGM Devices
  • 4.4.2. Shift Toward Personalized Care and Rising Health Awareness
  • 4.4.3. Increasing Accessibility for Diabetes Care Devices in Low- and Middle-income Countries
• 4.5. Challenges
  • 4.5.1. High Proportion of Undiagnosed Diabetes Population
  • 4.5.2. Issues Related to Adhesiveness, Reliability, and Accuracy of CGM Devices
• 4.6. Technology Trends/Market Trends
  • 4.6.1. Shift Toward Smart Devices and Advanced Healthcare with Artificial Intelligence
  • 4.6.2. Growing Adoption of Wearable Devices
  • 4.6.3. Growing Demand for Non-invasive CGM Devices
• 4.7. Regulatory Scenarios
• 4.8. Pricing Analysis
• 4.9. Case Studies
• 4.10. Porter's Five Forces Analysis

5. Continuous Glucose Monitoring Market-by Component

• 5.1. Overview
• 5.2. Sensors
  • 5.2.1. Disposable Sensors
  • 5.2.2. Implantable Sensors
• 5.3. Transmitters
• 5.4. Receivers

6. Continuous Glucose Monitoring Market-by Age Group

• 6.1. Overview
• 6.2. Adults
• 6.3. Children

7. Continuous Glucose Monitoring Market-by End User

• 7.1. Overview
• 7.2. Home Care Settings
• 7.3. Hospitals & Clinics

8. Continuous Glucose Monitoring Market-by Geography

• 8.1. Overview
• 8.2. North America
  • 8.2.1. U.S.
  • 8.2.2. Canada
• 8.3. Europe
  • 8.3.1. Germany
  • 8.3.2. France
  • 8.3.3. U.K.
  • 8.3.4. Italy
  • 8.3.5. Spain
  • 8.3.6. Norway
  • 8.3.7. Sweden
  • 8.3.8. Denmark
  • 8.3.9. Belgium
  • 8.3.10. Rest of Europe
• 8.4. Asia-Pacific
  • 8.4.1. Japan
  • 8.4.2. China
  • 8.4.3. India
  • 8.4.4. South Korea
  • 8.4.5. Rest of Asia Pacific
• 8.5. Latin America
  • 8.5.1. Brazil
  • 8.5.2. Mexico
  • 8.5.3. Rest of Latin America
• 8.6. Middle East & Africa

9. Competitive Analysis

• 9.1. Overview
• 9.2. Key Growth Strategies
• 9.3. Competitive Benchmarking
• 9.4. Competitive Dashboard
  • 9.4.1. Market Leaders
  • 9.4.2. Market Differentiators
  • 9.4.3. Vanguards
  • 9.4.4. Emerging Companies
• 9.5. Market Share Analysis/Market Ranking, by Key Players (2023)

10. Company Profiles (Company Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis*)

• 10.1. DexCom, Inc.
• 10.2. Abbott Laboratories
• 10.3. F. Hoffmann-La Roche Ltd
• 10.4. Medtronic plc
• 10.5. Nemaura Medical Inc.
• 10.6. i-Sens, Inc.
• 10.7. LifeScan, Inc.
• 10.8. Senseonics Holdings, Inc.
• 10.9. A. Menarini Diagnostics S.r.l
• 10.10. Medtrum Technologies, Inc.
• 10.11. B. Braun SE
• 10.12. Other Companies

(Note: SWOT Analysis will be Provided for The Top 5 Players)

11. Appendix

• 11.1. Available Customization
• 11.2. Related Reports